Back
iShares US Financials ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
73
IYF
iShares US Financials ETF
Last Price:
$109.19
Seasonality Move:
1%
Buy
63
RYTM
Rhythm Pharmaceuticals
Last Price:
$63.69
Seasonality Move:
15.42%
Buy
73
iShares US Financials ETF (IYF)
is a Buy
Is iShares US Financials ETF a Buy, Sell or Hold?
-
The current iShares US Financials ETF [IYF] share price is $109.19. The Score for IYF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
IYF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IYF Stock Price Chart
What is iShares US Financials ETF's stock price today?
-
The iShares US Financials ETF share price today is $109.19The current trend is relatively stagnant and IYF is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $63.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
IYF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1 | Sell |
| Relative Strength Index (14 RSI): | 52.41 | Buy |
| Chaikin Money Flow: | 61035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.32 - 112.88) | Buy |
| Bollinger Bands (100): | (108.29 - 117.75) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.28 | Buy |
| Relative Strength Index (14 RSI): | 63.66 | Buy |
| Chaikin Money Flow: | 369446 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.02 - 61.16) | Buy |
| Bollinger Bands (100): | (53.03 - 59.91) | Buy |
IYF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 106.65 | Buy |
| 20-day SMA: | 106.64 | Buy |
| 50-day SMA: | 111.25 | Sell |
| 200-day SMA: | 108.53 | Buy |
| 8-day EMA: | 107.26 | Buy |
| 20-day EMA: | 107.46 | Buy |
| 50-day EMA: | 109.85 | Sell |
| 200-day EMA: | 107.42 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.43 | Buy |
| 20-day SMA: | 57.42 | Buy |
| 50-day SMA: | 55.27 | Buy |
| 200-day SMA: | 53.46 | Buy |
| 8-day EMA: | 61.16 | Buy |
| 20-day EMA: | 58.64 | Buy |
| 50-day EMA: | 56.64 | Buy |
| 200-day EMA: | 52.62 | Buy |
iShares US Financials ETF Earnings Growth & IYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
iShares US Financials ETF Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||